HS-1793

HS-1793 is a Resveratrol (HY-16561) analogue with antitumor activities in a variety of cancer cell lines[1]. HS-1793 induces cell apoptosis[2].

Product Specifications

CAS Number

[927885-00-5]

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

Apoptosis

Type

Reference compound

Related Pathways

Apoptosis

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/hs-1793.html

Purity

99.26

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

OC1=CC=C(C2=CC=C3C=C(O)C=CC3=C2)C(O)=C1

Molecular Formula

C16H12O3

Molecular Weight

252.26

Precautions

H302, H315, H319

References & Citations

[1]Kim DH, et al. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model. Int J Oncol. 2017 Aug;51 (2) :715-723.|[2]Kim DH, et al. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells. Oncol Rep. 2017 Jan;37 (1) :281-288.